What is the IMPACTT study?

The IMProving Adherence to Colonoscopy through Teams and Technology (IMPACTT) study aims to improve colorectal cancer (CRC) screening among vulnerable populations.

CRC is the second leading cause of cancer death in the United States. Despite the effectiveness of CRC screening, it is underused, and late-stage CRC and CRC-based mortality remain disproportionately high in racial/ethnic minority populations and in safety-net health systems.

The IMPACTT study uses a multilevel approach to support and increase the completion of a diagnostic colonoscopy following an abnormal fecal immunochemical test (FIT) by patients in the San Francisco Health Network.